Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |